Paraplegia Clinical Trial
Official title:
The ReWalk Exoskeletal Walking System for Persons With Paraplegia
It is well appreciated that an extreme sedentary lifestyle from paralysis, contributes to many secondary medical problems such as diabetes and insulin resistance, obesity, constipation, poor blood pressure regulation, cardiovascular disease, reduced quality of life, and more. The ReWalk-I exoskeleton walking device permits investigation of the potential benefits of frequent upright posture and walking on many of the secondary consequences of spinal cord injury. The researchers are investigating the ability of persons with paraplegia to learn to stand and walk with the ReWalk-I and the effects of being upright and walking on several of these secondary medical consequences of spinal cord injury.
Potential participants will be pre-screened with the inclusion criteria for eligibility. The informed consent process will begin for those participants who have been determined to meet the inclusion criteria. After the potential participant's signed consent has been provided, further evaluations for eligibility will be performed (e.g., there are several medical and physical exclusion criteria). Those potential participants who meet both the inclusion and exclusion criteria will be eligible to enroll into the ReWalk-I study. Baseline evaluations and personalized measurements for fitting to the ReWalk-I will be performed over one week, before the training sessions begin. The ReWalk sessions will consist of a Learning Phase (12 sessions in 4 weeks) and a Training Phase (18 sessions in 6 weeks). These times may vary by each participant's ReWalk learning curve. Training will begin with sit-to-stand, stand-to-sit, and standing balance activities. Progression to walking will occur as skills advance. Each session will be an average 50 minutes, with 3 sessions per week. The skills to be learned include 1) sit-to-stand, 2) stand-to-sit, 3) 2-arm standing balance, 4) 1-arm standing balance, 5) walking, and 6) stair climbing. The study evaluations will be repeated after the Learning Phase, after the Training Phase and 1-month post training follow-up. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04736849 -
Epidural and Dorsal Root Stimulation in Humans With Spinal Cord Injury
|
N/A | |
Terminated |
NCT00429013 -
Pressure Ulcer Formation Prevention in Paraplegics Using Computer and Sensory Substitution Via the Tongue.
|
Phase 2 | |
Completed |
NCT00838838 -
Efficacy of Nebido on Bone Mineral Density (BMD) in Hypogonadal Paraplegic Patients With Confirmed Osteoporosis
|
N/A | |
Completed |
NCT05563402 -
"Evaluation of Usability and Safety of the Self-balancing Walking System Atalante in Patients With Multiple Sclerosis"
|
N/A | |
Recruiting |
NCT05432999 -
Extracorporeal Shockwave Therapy for Spasticity in People With Spinal Cord Injury
|
N/A | |
Enrolling by invitation |
NCT02602639 -
Functional Electrical Stimulation With Rowing as Exercise After Spinal Cord Injury
|
N/A | |
Completed |
NCT00385918 -
Robotically Assisted Treadmill Training in Spinal Cord Injury (SCI)
|
N/A | |
Recruiting |
NCT04397250 -
High-intensity Interval Training for Cardiometabolic Health in Persons With Spinal Cord Injury
|
N/A | |
Terminated |
NCT02412046 -
Quantification of the Pressure Threshold Related to Tissue Injury in Bedriden Paraplegics
|
N/A | |
Completed |
NCT06169969 -
Effect Of Magnetic Therapy In Bladder Dysfunction And Quality Of Life In Paraplegic Patients
|
N/A | |
Recruiting |
NCT01474148 -
A Neuroprosthesis for Seated Posture and Balance
|
N/A | |
Terminated |
NCT03114345 -
Correlation Between Pressure Differences and Micro-vascularization Changes in Bedridden Paraplegic Patient
|
N/A | |
Active, not recruiting |
NCT02600910 -
Natural History of Shoulder Pathology in Manual Wheelchair Users
|
||
Completed |
NCT01739023 -
Safety of Autologous Human Schwann Cells (ahSC) in Subjects With Subacute SCI
|
Phase 1 | |
Terminated |
NCT01498991 -
Spinal Cord Injury Leg Rehabilitation
|
Phase 1/Phase 2 | |
Recruiting |
NCT06072001 -
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis
|
Phase 3 | |
Recruiting |
NCT06071949 -
Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis
|
Phase 3 | |
Completed |
NCT04215081 -
ExoAtlet II For SCI Patients
|
N/A | |
Completed |
NCT04110561 -
Evaluation of Safety and Performance of the Atalante System With Patients With Lower Limb Paralysis
|
N/A | |
Completed |
NCT00270855 -
Exercise to Reduce Obesity in Spinal Cord Injury
|
N/A |